25. Share-based benefits

2025

2024

Number

of share
options

Weighted

average

exercise

price (p)

Number

of share
options

Weighted

average

exercise

price (p)

Outstanding at the beginning of the year

102,037

351

127,415

345

Exercised during the year

(15,406)

324

(17,265)

359

Granted during the year

78,354

327

9,537

419

Forfeited during the year

(14,304)

348

(17,650)

340

Outstanding at the end of the year

150,681

342

102,037

351

Exercisable at the end of the year

64,826

343

59,035

345

2025

2024

Number

of share
options

Weighted

average

exercise

price (p)

Number

of share
options

Weighted

average

exercise

price (p)

Outstanding at the beginning of the year

1,296,632

1,181,012

Exercised during the year

(180,522)

(68,437)

Granted during the year

656,217

418,894

Dividend on granted

9,974

Forfeited during the year

(83,317)

(234,837)

Failed to vest

(88,993)

Outstanding at the end of the year

1,609,991

1,296,632

Exercisable at the end of the year

317,014

147,734

2025

2024

Number

of share
options

Weighted

average

exercise

price (p)

Number

of share
options

Weighted

average

exercise

price (p)

Outstanding at the beginning of the year

139,980

77,510

Exercised during the year

(12,726)

(12,870)

Granted during the year

111,636

75,340

Dividend on granted

533

Outstanding at the end of the year

239,423

139,980

Exercisable at the end of the year

18-Apr-23

8-Apr-24

8-Apr-25

Share price (p)

394.0

419.3

327.3

Exercise price (p)

394.0

359.1

324.5

Expected volatility

39%

46%

46%

Option life

Three years

Three years

Three years

Expected dividends (p) (assumed to be increasing at 2.5% p.a.)

7.1

7.5

7.8

Risk-free interest rate (based on national government bonds)

3.75%

3.75%

3.75%

Fair value at grant date (p)

106.0

80.6

102.3

2025

£’000

2024

£’000

Within administrative expenses

– share-based payment charge

1,328

1,077

– related National Insurance

346

105